Stem Cell‐Based Tactics for the Modeling and Treatment of Neurological Disorders

Neurological disorders such as diverse neurodegenerative diseases and neural tumors have posed significant challenges to the well-being of the individuals and the healthcare systems of the economic society worldwide. Despite the robust progress in the diagnosis and treatment of neurological disorders in clinical practice, the continuous recurrence and deterioration attribute to the multifactorial conditions and the underlying regulatory network are still intractable for clinicians to pinpoint their exact pathogenesis and propose effective countermeasures. Stem cells are populations with unique self-renewal and multi-lineage differentiation properties, which are extensively involved in early embryonic development, disease modeling, pharmacological screening, and disease interventions including neurological disorders. Consequently, they represent a novel tactics with promising prospects for the purposes of refractory and recurrent neurological disease administration alone or integrated with the multifaceted innovations in bioengineering and biomedicine. In this review article, we mainly outline the methodology of neural differentiation of human stem cells including human pluripotent stem cells (hPSCs) and neural stem cells (NSCs), the construction and application of stem cell-based neural organoids for diverse neural disorder modeling, together with the stem cell-based regimens including mesenchymal stem/stromal cells (MSCs) for the treatment of neurodegenerative diseases and hPSCs-derived immune cells (e.g., natural killer cells, chimeric antigen receptor-transduced T cells) for neural tumor administration. Furthermore, the promising prospects and the concomitant challenges of stem cell-based tactics for neurological disorders have also be expounded. Collectively, we are aiming to put forward the state-of-the-art renewal of stem cell-based preclinical and clinical investigations, which would benefit the further development of novel therapeutic options for neural disorders including neurodegenerative diseases.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-05-12
DOI
https://doi.org/10.1096/fj.202600014rr
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stem Cell‐Based Tactics for the Modeling and Treatment of Neurological Disorders

邴英, Mingzhi Song, Leisheng Zhang, Mingyi Xu et al.
The FASEB Journal
Pluripotent Stem Cells Research
article

Stem Cell‐Based Tactics for the Modeling and Treatment of Neurological Disorders

邴英, Mingzhi Song, Leisheng Zhang, Mingyi Xu, Yuxing Wang, Jinwen Li, Gang Su, Min Cheng, Dianlong Hou, Wen Gao, Haiying Zhu, Heng Zhu, Junhua Li, Shanshan Zhang
article en

Abstract

Neurological disorders such as diverse neurodegenerative diseases and neural tumors have posed significant challenges to the well-being of the individuals and the healthcare systems of the economic society worldwide. Despite the robust progress in the diagnosis and treatment of neurological disorders in clinical practice, the continuous recurrence and deterioration attribute to the multifactorial conditions and the underlying regulatory network are still intractable for clinicians to pinpoint their exact pathogenesis and propose effective countermeasures. Stem cells are populations with unique self-renewal and multi-lineage differentiation properties, which are extensively involved in early embryonic development, disease modeling, pharmacological screening, and disease interventions including neurological disorders. Consequently, they represent a novel tactics with promising prospects for the purposes of refractory and recurrent neurological disease administration alone or integrated with the multifaceted innovations in bioengineering and biomedicine. In this review article, we mainly outline the methodology of neural differentiation of human stem cells including human pluripotent stem cells (hPSCs) and neural stem cells (NSCs), the construction and application of stem cell-based neural organoids for diverse neural disorder modeling, together with the stem cell-based regimens including mesenchymal stem/stromal cells (MSCs) for the treatment of neurodegenerative diseases and hPSCs-derived immune cells (e.g., natural killer cells, chimeric antigen receptor-transduced T cells) for neural tumor administration. Furthermore, the promising prospects and the concomitant challenges of stem cell-based tactics for neurological disorders have also be expounded. Collectively, we are aiming to put forward the state-of-the-art renewal of stem cell-based preclinical and clinical investigations, which would benefit the further development of novel therapeutic options for neural disorders including neurodegenerative diseases.

The FASEB JournalVol. 40(10)
Weifang Medical University (CN), People’s Hospital of Rizhao (CN), Second Hospital of Shandong University (CN), Jining Medical University (CN)
Natural Science Foundation of Jiangxi Province, Natural Science Foundation of Hunan Province, Natural Science Foundation of Shandong Province
Openalex Percentile: Top 8%
Pluripotent Stem Cells Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.